Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: Emerillon Capital

JLABS @ Toronto

Thursday, May 4, 2017 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: Emerillon Capital

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info 3d 16h 50m CA$15.00 CA$1.51
Volunteer   more info Ended Free CA$0.00
Media/Press   more info Ended Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: Emerillon Capital

Event Details

Are you looking for a partner who can adapt to your venture project?

On May 4th, JLABS @ Toronto invites Emerillon Capital Investment Director, Nicola Urbani, to our “Investor Spotlight” to discuss:

  • Practical tips on what he looks for in a pitch
  • Emerillon Capital’s areas of interest – what are they investing in?
  • Case studies of successful investments
  • How to increase your chances of successful fundraising


Launched in Montreal in June 2013, Emerillon Capital (backed by its lead financial sponsor CM-CIC Investissement) is a venture capital fund with a patient capital and flexible approach. It is dedicated to supporting and investing in companies positioned in expanding sectors showing strong potential for growth. Emerillon is specialized in equity (or quasi-equity) investments and support of companies with strong technological expertise in their early development phases: pre-revenue, commercial start-up and first expansion.

If interested in meeting one-on-one with Nicola after his presentation, please fill out an application here: www.jnjawards.fluidreview.com

Agenda:
10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on April 13, 2017.

Fees:
$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 3rd (or sold out).

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Speaker:
Nicola Urbani | Investment Director, Emerillon Capital
A management and investment professional with a passion for innovation and broad experience (13 years) in venture capital investment in life sciences and cleantech industries. Worked in two different venture capital Fund managers with a total committed capital of over $400M: GeneChem management (with 4 different Funds targeting different stages and indications: GeneChem Technologies, GeneChem Therapeutics, AgeChem Financial, and AmorChem Financial) and Emerillon Capital. Served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier Canadian and international venture capital Funds. Led several in-and out-licensing deals in life sciences and cleantech.
Immediately prior to joining Emerillon, Nicola was VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and the creation of companies. Nicola has a PhD in molecular genetics from McGill University and an MBA from Université du Québec à Montréal.
Connect with Nicola:   Connect on LinkedIn

Have questions about Investor Spotlight: Emerillon Capital? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where


JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1
Canada

Thursday, May 4, 2017 from 10:30 AM to 1:00 PM (EDT)


  Add to my calendar

Organizer

JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
Investor Spotlight: Emerillon Capital
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.